Treatment of Akata Ebv-Positive Cells with Doxorubicin Causes More Ebv Reactivation than Treatment with Etoposide
AuthID
P-002-Y6G
P-002-Y6G
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service